Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Seres and Nestlé enter up to $525m deal for microbiome therapeutic

pharmaceutical-technologyJuly 05, 2021

Tag: Seres , Nestlé , SER-109 , CDI

PharmaSources Customer Service